我国部分地区医药价格综合改革比较研究  

Comparative Study of Comprehensive Reform of the Pharmaceutical Price in Some Places in China

作　　者：吴春艳[1,2] 代涛[2] 杨越涵[2] 

机构地区：[1]北京协和医学院,北京100730 [2]中国医学科学院医学信息研究所,北京100020

出　　处：《中国医院管理》2017年第2期1-4,共4页Chinese Hospital Management

摘　　要：目的了解我国部分典型地区城市公立医院医药价格综合改革的特点和存在的问题。方法基于内容分析方法,运用多机制框架比较分析浙江省、安徽省、江苏省和青海省4省城市公立医院医药价格综合改革的具体做法。结果研究发现,政策协同性和激励作用有待加强,政府责任有待加强,尚未形成科学、完善的医疗服务价格形成机制,医保作用未充分发挥,药品流通领域仍存在挤压空间。结论建议采取多机制联动的医药价格改革,进一步强化政府投入和调控责任,逐步建立科学、完善的医疗服务价格形成机制,充分发挥医保控费、补偿和约束引导作用,进一步挤压药品流通领域水分。Objective To understand features and existing problems of comprehensive reform of the pharmaceutical price in urban public hospitals in partial priority areas. Methods Based on content analysis method, using multi-mechanism frame to compare and analyze the comprehensive reform of the pharmaceutical price in urban public hospitals of Zhejiang Province, Anhui Province, Jiangsu Province and Qinghai Province. Results Research findings were： the policy coordination and incentive role needs to be strengthened, the government’s responsibility needs to be strengthened, a scientific and perfect medical service price formation mechanism has not been formed, the role of Health insurance is not fully developed, and price space still exists in pharmaceutical distribution systems. Conclusion The policy implications were as follows： implementing pharmaceutical price reform with multi-mechanism linkage, further strengthening government investment and control responsibilities, forming a scientific and perfect medical service price formation mechanism gradually, giving full play to controlling fees, compensation and restraint guidance role of health insurance, and further squeezing the space in pharmaceutical distribution systems.

关 键 词：取消药品加成 医疗服务价格 综合改革 城市公立医院 

分 类 号：R197.1[医药卫生—卫生事业管理]